As of February 2026 GenSight Biologics has a market cap of ยฃ14.57 Million. This makes GenSight Biologics the world's 10155th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.